The artificial saliva market size has grown rapidly in recent years. It will grow from $1.72 billion in 2023 to $1.95 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. Historical growth can be ascribed to increasing demand for oral sprays, gels, and liquids, broadening treatment options for cancer patients, a growing elderly population, rising disposable incomes, and an increase in dental disorders globally.
The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. Forecasted growth can be attributed to heightened awareness of oral hygiene importance, the rising prevalence of dry mouth syndrome (xerostomia), growing demand for artificial saliva, increasing cancer incidences and chemotherapy treatments. Key trends in the forecast period include expanded research and development efforts, advancements in product formulation, integration of advanced technologies, technological innovations in dry mouth treatments, and a shift towards natural and biocompatible ingredients.
The increasing prevalence of dry mouth syndrome is expected to drive growth in the artificial saliva market. Dry mouth syndrome, or xerostomia, is characterized by persistent mouth dryness, exacerbated by factors such as aging and the widespread use of medications. Artificial saliva helps moisturize oral tissues, alleviating the discomfort associated with xerostomia. For instance, a study by Faculdade Meridional found a 19.1% prevalence of xerostomia among 293 older adults in Brazil in 2021. Similarly, research by the University of Gothenburg reported a 43.6% prevalence among 374 adult patients seeking primary healthcare in 2022. These trends underscore the role of rising xerostomia cases in fueling demand for artificial saliva.
Leading companies in the artificial saliva market are focusing on enhancing products with mucin to improve effectiveness in managing dry mouth. These formulations closely mimic natural saliva properties, providing superior relief. For example, Pickering Laboratories launched a 950 mL size Artificial Saliva with Mucin in October 2021, featuring a mineral composition and pH similar to human saliva, with added mucin for viscosity and lubrication. This stabilized solution, suitable for various applications including dental and pharmaceutical studies, remains effective at room temperature due to a built-in preservative.
In March 2023, Hologram Sciences collaborated with Haleon to develop personalized health products, leveraging Haleon's expertise in consumer healthcare. Haleon, known for science-backed solutions, offers artificial saliva products that address dry mouth and support oral health, aligning with the market's growing needs.
Major companies operating in the artificial saliva market are Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone.
North America was the largest region in the artificial saliva market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial saliva market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Artificial saliva is a synthetic product created to replicate the functions of natural saliva, primarily used to alleviate dry mouth (xerostomia) resulting from conditions such as Sjögren's syndrome, cancer radiation therapy, or certain medications. It helps by moisturizing and lubricating the mouth, facilitating chewing and swallowing, and enhancing oral comfort.
The main types of artificial saliva products include oral spray, oral solution, oral liquid, dissolving tablets, gel, and powder. Oral spray is formulated as a spray to temporarily relieve dry mouth symptoms by providing lubrication and moisture to the oral cavity. Distribution channels for these products include supermarkets, hypermarkets, and other retail outlets, catering to both adults and children as end-users.
The artificial saliva market research report is one of a series of new reports that provides artificial saliva market statistics, including the artificial saliva industry global market size, regional shares, competitors with artificial saliva market share, detailed artificial saliva market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial saliva industry. These artificial saliva market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial saliva market consists of sales of sprays, gels, and lozenges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.27 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. Forecasted growth can be attributed to heightened awareness of oral hygiene importance, the rising prevalence of dry mouth syndrome (xerostomia), growing demand for artificial saliva, increasing cancer incidences and chemotherapy treatments. Key trends in the forecast period include expanded research and development efforts, advancements in product formulation, integration of advanced technologies, technological innovations in dry mouth treatments, and a shift towards natural and biocompatible ingredients.
The increasing prevalence of dry mouth syndrome is expected to drive growth in the artificial saliva market. Dry mouth syndrome, or xerostomia, is characterized by persistent mouth dryness, exacerbated by factors such as aging and the widespread use of medications. Artificial saliva helps moisturize oral tissues, alleviating the discomfort associated with xerostomia. For instance, a study by Faculdade Meridional found a 19.1% prevalence of xerostomia among 293 older adults in Brazil in 2021. Similarly, research by the University of Gothenburg reported a 43.6% prevalence among 374 adult patients seeking primary healthcare in 2022. These trends underscore the role of rising xerostomia cases in fueling demand for artificial saliva.
Leading companies in the artificial saliva market are focusing on enhancing products with mucin to improve effectiveness in managing dry mouth. These formulations closely mimic natural saliva properties, providing superior relief. For example, Pickering Laboratories launched a 950 mL size Artificial Saliva with Mucin in October 2021, featuring a mineral composition and pH similar to human saliva, with added mucin for viscosity and lubrication. This stabilized solution, suitable for various applications including dental and pharmaceutical studies, remains effective at room temperature due to a built-in preservative.
In March 2023, Hologram Sciences collaborated with Haleon to develop personalized health products, leveraging Haleon's expertise in consumer healthcare. Haleon, known for science-backed solutions, offers artificial saliva products that address dry mouth and support oral health, aligning with the market's growing needs.
Major companies operating in the artificial saliva market are Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone.
North America was the largest region in the artificial saliva market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial saliva market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Artificial saliva is a synthetic product created to replicate the functions of natural saliva, primarily used to alleviate dry mouth (xerostomia) resulting from conditions such as Sjögren's syndrome, cancer radiation therapy, or certain medications. It helps by moisturizing and lubricating the mouth, facilitating chewing and swallowing, and enhancing oral comfort.
The main types of artificial saliva products include oral spray, oral solution, oral liquid, dissolving tablets, gel, and powder. Oral spray is formulated as a spray to temporarily relieve dry mouth symptoms by providing lubrication and moisture to the oral cavity. Distribution channels for these products include supermarkets, hypermarkets, and other retail outlets, catering to both adults and children as end-users.
The artificial saliva market research report is one of a series of new reports that provides artificial saliva market statistics, including the artificial saliva industry global market size, regional shares, competitors with artificial saliva market share, detailed artificial saliva market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial saliva industry. These artificial saliva market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artificial saliva market consists of sales of sprays, gels, and lozenges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Artificial Saliva Market Characteristics3. Artificial Saliva Market Trends and Strategies32. Global Artificial Saliva Market Competitive Benchmarking33. Global Artificial Saliva Market Competitive Dashboard34. Key Mergers and Acquisitions in the Artificial Saliva Market
4. Artificial Saliva Market - Macro Economic Scenario
5. Global Artificial Saliva Market Size and Growth
6. Artificial Saliva Market Segmentation
7. Artificial Saliva Market Regional and Country Analysis
8. Asia-Pacific Artificial Saliva Market
9. China Artificial Saliva Market
10. India Artificial Saliva Market
11. Japan Artificial Saliva Market
12. Australia Artificial Saliva Market
13. Indonesia Artificial Saliva Market
14. South Korea Artificial Saliva Market
15. Western Europe Artificial Saliva Market
16. UK Artificial Saliva Market
17. Germany Artificial Saliva Market
18. France Artificial Saliva Market
19. Italy Artificial Saliva Market
20. Spain Artificial Saliva Market
21. Eastern Europe Artificial Saliva Market
22. Russia Artificial Saliva Market
23. North America Artificial Saliva Market
24. USA Artificial Saliva Market
25. Canada Artificial Saliva Market
26. South America Artificial Saliva Market
27. Brazil Artificial Saliva Market
28. Middle East Artificial Saliva Market
29. Africa Artificial Saliva Market
30. Artificial Saliva Market Competitive Landscape and Company Profiles
31. Artificial Saliva Market Other Major and Innovative Companies
35. Artificial Saliva Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Artificial Saliva Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on artificial saliva market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial saliva? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial saliva market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product: Oral Spray; Oral Solution; Oral Liquid; Dissolving Tablets; Gel; Powder2) By Distributional Channel: Supermarkets; Hypermarkets; Other Distribution Channels
3) By End-User: Adult; Pediatric
Key Companies Mentioned: Pfizer Inc.; Amgen Inc.; Viatris Inc.; Bausch Health Companies Inc.; Perrigo Company plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Pfizer Inc.
- Amgen Inc.
- Viatris Inc.
- Bausch Health Companies Inc.
- Perrigo Company plc
- Aurobindo Pharma
- Cipla
- Hikma Pharmaceuticals plc
- RECORDATI
- Mankind Pharma Ltd.
- Quantum Health Inc.
- Mission Pharmacal Company
- Cumberland Pharmaceuticals Inc.
- DENTAID
- Parnell Pharmaceuticals Inc.
- Forward Science
- ICPA Health Products Ltd.
- Saliwell Ltd.
- Livealth
- CCMed Ltd.
- Nanochemazone
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | August 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 1.95 Billion |
Forecasted Market Value ( USD | $ 3.27 Billion |
Compound Annual Growth Rate | 13.8% |
Regions Covered | Global |
No. of Companies Mentioned | 21 |